NVCT News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-21 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-08-04 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-06-30 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2026-06-29 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 8.01. |
| 2026-06-23 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2026-06-12 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 5.07. |
| 2026-05-05 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-02-11 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-11-04 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-09-25 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2025-08-05 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-06-13 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 5.07. |
| 2025-05-09 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2025-05-06 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-02-25 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-02-06 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2024-11-05 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-08-29 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2024-08-06 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-06-13 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 5.07. |
| 2024-05-07 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-03-05 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-11-08 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-09-12 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2023-08-17 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2023-08-09 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-07-03 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02. |
| 2023-06-16 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 5.02,5.07,9.01. |
| 2023-05-15 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-05-10 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-03-07 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-11-08 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-08-05 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-07-29 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 1.01,3.02,8.01,9.01. |
| 2022-05-11 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-03-22 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 2.02,5.02,9.01. |
| 2022-02-04 | Current report | SEC filing | Nuvectis Pharma, Inc. filed Form 8-K | Nuvectis Pharma, Inc. filed Form 8-K covering items 1.01,5.03,9.01. |